Related Experiment Videos
Resveratrol mimics ischemic preconditioning in the brain
Ami P Raval1, Kunjan R Dave, Miguel A Pérez-Pinzón
1Department of Neurology and Neuroscience Program, Cerebral Vascular Disease Research Center, University of Miami School of Medicine, Florida 33101, USA.
Summary
Resveratrol, a natural compound, mimics ischemic preconditioning (IPC) to protect brain cells from damage by activating the SIRT1 pathway. This finding offers potential new therapies for stroke and neurosurgery.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Caloric restriction and resveratrol increase silent information regulator 2/sirtuin 1 (SIRT1) activity, enhancing lifespan and cell survival.
- Resveratrol is a known cardioprotective phytoalexin.
- Ischemic preconditioning (IPC) confers cardio- and cerebroprotection against ischemia.
Purpose of the Study:
- To determine if resveratrol can replicate the neuroprotective effects of IPC against cerebral ischemia.
- To investigate the role of the SIRT1 pathway in resveratrol-induced neuroprotection.
Main Methods:
- Utilized an in vitro organotypic hippocampal slice culture model of cerebral ischemia.
- Administered resveratrol pretreatment.
- Investigated the effect of SIRT1 activation blockade using sirtinol.
Main Results:
- Resveratrol pretreatment successfully mimicked the neuroprotective effects of IPC in the hippocampal slice model.
- The neuroprotection mediated by both IPC and resveratrol was abolished when SIRT1 activation was blocked by sirtinol.
- This indicates that resveratrol's neuroprotective action is dependent on the SIRT1 pathway.
Conclusions:
- Resveratrol emulates IPC-induced neuroprotection against cerebral ischemia through the SIRT1 pathway.
- Understanding resveratrol's mechanism for inducing ischemic tolerance could lead to novel prophylactic therapies for stroke and neurosurgery.